• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国新生儿病房微创表面活性剂给药(LISA)实践的变化

Changes in practice of less-invasive surfactant administration (LISA) in United Kingdom neonatal units.

作者信息

Shetty Sandeep, Tolentino Donna, Lau Cheryl, Duffy Donovan, Greenough Anne

机构信息

Neonatal Intensive Care Centre, St George's University Hospitals NHS Foundation Trust, London, UK.

St George's University of London, London, UK.

出版信息

Acta Paediatr. 2025 Feb;114(2):393-397. doi: 10.1111/apa.17446. Epub 2024 Oct 8.

DOI:10.1111/apa.17446
PMID:39377490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11706752/
Abstract

AIM

To determine whether the use of less-invasive surfactant administration (LISA) had changed between 2018 and 2024.

METHODS

An online questionnaire was sent to all 191 neonatal units between June 2023 and May 2024. One consultant from each neonatal unit was randomly selected. Follow-up was done by telephone (middle-grade doctor grade and above or alternatively to Advanced Neonatal Nurse Practitioners) for the non-responders.

RESULTS

Response rate was 100%from 191 units neonatal units. LISA was used in 134 (70%) neonatal units in 2024 compared to 35 (18.7%) units in 2018 (p < 0.001). The reason why LISA was not performed was lack of experience/training (51%) or not having a standardised practice/guideline (49%). LISA in the delivery suite (DS) had increased from 2% in 2018 to 16% in 2024, and the use of video laryngoscope for LISA is becoming standard of practice. The oxygen requirement criteria for the use of LISA in both the DS and on neonatal unit had reduced to FiO2 of 0.3 or more.

CONCLUSION

The uptake of LISA had increased in the United Kingdom. There is greater use of LISA in the DS. Lack of training and expertise were the major limiting factors for LISA not being performed.

摘要

目的

确定2018年至2024年间,微创表面活性剂给药(LISA)的使用情况是否发生了变化。

方法

在2023年6月至2024年5月期间,向所有191个新生儿病房发送了在线调查问卷。每个新生儿病房随机挑选一名顾问。对于未回复者,通过电话(中级及以上医生级别,或者高级新生儿护士从业者)进行随访。

结果

191个新生儿病房的回复率为100%。2024年,134个(70%)新生儿病房使用了LISA,而2018年为35个(18.7%)病房(p < 0.001)。未进行LISA的原因是缺乏经验/培训(51%)或没有标准化操作/指南(49%)。分娩室(DS)中LISA的使用从2018年的2%增加到2024年的16%,并且用于LISA的视频喉镜的使用正在成为标准操作。在DS和新生儿病房中使用LISA的氧需求标准已降至FiO2为0.3或更高。

结论

在英国,LISA的采用率有所提高。在DS中LISA的使用更为广泛。缺乏培训和专业知识是未进行LISA的主要限制因素。

相似文献

1
Changes in practice of less-invasive surfactant administration (LISA) in United Kingdom neonatal units.英国新生儿病房微创表面活性剂给药(LISA)实践的变化
Acta Paediatr. 2025 Feb;114(2):393-397. doi: 10.1111/apa.17446. Epub 2024 Oct 8.
2
Less Invasive Surfactant Administration in Preterm Infants in Tertiary Neonatal Intensive Care Units in Germany: A Survey.德国三级新生儿重症监护病房中早产儿的微创表面活性剂给药:一项调查
Neonatology. 2025;122(1):46-55. doi: 10.1159/000539302. Epub 2024 Jul 17.
3
Comparison of Outcomes of Less Invasive Surfactant Administration in Prematurely Born Infants in the Delivery Suite and the Neonatal Unit.比较在产房和新生儿病房中对早产儿进行微创表面活性剂给药的效果。
Am J Perinatol. 2024 May;41(S 01):e2674-e2678. doi: 10.1055/a-2142-9434. Epub 2023 Jul 27.
4
Effectiveness and safety profile of introducing less invasive surfactant administration in management of respiratory distress syndrome: A retrospective cohort study in a tertiary neonatal unit in Hong Kong.在呼吸窘迫综合征管理中引入侵入性较小的表面活性剂给药的有效性和安全性:香港一家三级新生儿病房的回顾性队列研究。
Pediatr Neonatol. 2025 Mar;66(2):147-151. doi: 10.1016/j.pedneo.2023.12.013. Epub 2024 Jul 6.
5
Survey of less Invasive Surfactant Administration in England, slow adoption and variable practice.英格兰微创表面活性剂给药调查:采用缓慢且实践方式各异
Acta Paediatr. 2020 Mar;109(3):505-510. doi: 10.1111/apa.14995. Epub 2019 Sep 16.
6
Should less invasive surfactant administration (LISA) become routine practice in US neonatal units?在美国新生儿病房中,是否应将侵入性更小的表面活性剂给药(LISA)常规化?
Pediatr Res. 2023 Apr;93(5):1188-1198. doi: 10.1038/s41390-022-02265-8. Epub 2022 Aug 19.
7
Clinical evaluation of an application aid for less-invasive surfactant administration (LISA).一种用于微创表面活性剂给药(LISA)的应用辅助设备的临床评估。
Arch Dis Child Fetal Neonatal Ed. 2021 Mar;106(2):211-214. doi: 10.1136/archdischild-2020-319792. Epub 2020 Oct 6.
8
Less Invasive Surfactant Administration in Spain: A Survey Regarding Its Practice, the Target Population, and Premedication Use.西班牙的微创表面活性剂给药:一项关于其应用实践、目标人群和用药前准备的调查。
Am J Perinatol. 2020 Feb;37(3):277-280. doi: 10.1055/s-0039-1678534. Epub 2019 Feb 4.
9
European perspective on less invasive surfactant administration-a survey.欧洲对于微创表面活性剂给药的观点——一项调查
Eur J Pediatr. 2017 Feb;176(2):147-154. doi: 10.1007/s00431-016-2812-9. Epub 2016 Dec 9.
10
Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.经鼻给予肺表面活性物质与气管内给予肺表面活性物质后行小潮气量通气治疗中国呼吸窘迫综合征早产儿的随机对照试验研究方案
Trials. 2020 Jun 11;21(1):516. doi: 10.1186/s13063-020-04390-3.

引用本文的文献

1
Surfactant treatment rate in very premature infants following change to less-invasive surfactant administration.改为采用侵入性较小的表面活性剂给药方式后极早产儿的表面活性剂治疗率。
Eur J Pediatr. 2025 Aug 19;184(9):563. doi: 10.1007/s00431-025-06406-z.

本文引用的文献

1
NON-pharmacological Approach Less Invasive Surfactant Administration (NONA-LISA) trial: protocol for a randomised controlled trial.非药物性肺泡表面活性物质给药(NONA-LISA)试验:一项随机对照试验方案。
Pediatr Res. 2024 Sep;96(4):1084-1089. doi: 10.1038/s41390-023-02998-0. Epub 2024 Jan 11.
2
Evaluation of a respiratory care protocol including less invasive surfactant administration in preterm infants.评估包括经鼻持续气道正压通气联合肺表面活性物质治疗的早产儿呼吸管理方案
Pediatr Res. 2024 May;95(6):1603-1610. doi: 10.1038/s41390-023-02963-x. Epub 2023 Dec 14.
3
Clinical decision thresholds for surfactant administration in preterm infants: a systematic review and network meta-analysis.早产儿表面活性剂给药的临床决策阈值:一项系统评价和网状荟萃分析。
EClinicalMedicine. 2023 Jul 20;62:102097. doi: 10.1016/j.eclinm.2023.102097. eCollection 2023 Aug.
4
Curriculum and assessment tool for less invasive surfactant administration: an international Delphi consensus study.经鼻持续气道正压通气与鼻塞持续气道正压通气治疗新生儿呼吸窘迫综合征的系统评价和 Meta 分析
Pediatr Res. 2023 Sep;94(3):1216-1224. doi: 10.1038/s41390-023-02621-2. Epub 2023 May 4.
5
European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update.欧洲呼吸窘迫综合征管理共识指南:2022 年更新版。
Neonatology. 2023;120(1):3-23. doi: 10.1159/000528914. Epub 2023 Feb 15.
6
Association of Administration of Surfactant Using Less Invasive Methods With Outcomes in Extremely Preterm Infants Less Than 27 Weeks of Gestation.应用更少有创方法的表面活性剂给药与胎龄小于 27 周的极早产儿结局的相关性。
JAMA Netw Open. 2022 Aug 1;5(8):e2225810. doi: 10.1001/jamanetworkopen.2022.25810.
7
Sedation for less invasive surfactant administration in preterm infants: a systematic review and meta-analysis.早产儿应用较少有创性表面活性剂时的镇静:系统评价和荟萃分析。
Pediatr Res. 2023 Feb;93(3):471-491. doi: 10.1038/s41390-022-02121-9. Epub 2022 Jun 2.
8
Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.微创表面活性剂治疗与假治疗对呼吸窘迫综合征早产儿的死亡或支气管肺发育不良的影响:OPTIMIST 随机临床试验。
JAMA. 2021 Dec 28;326(24):2478-2487. doi: 10.1001/jama.2021.21892.
9
Surfactant Nebulization to Prevent Intubation in Preterm Infants: A Systematic Review and Meta-analysis.表面活性物质雾化预防早产儿插管:系统评价和荟萃分析。
Pediatrics. 2021 Nov;148(5). doi: 10.1542/peds.2021-052504. Epub 2021 Oct 28.
10
Less-Invasive Surfactant Administration for Neonatal Respiratory Distress Syndrome: A Consensus Guideline.经鼻持续气道正压通气与鼻塞式持续气道正压通气治疗早产儿呼吸窘迫综合征的临床多中心随机对照研究
Neonatology. 2021;118(5):586-592. doi: 10.1159/000518396. Epub 2021 Sep 2.